Detalhe da pesquisa
1.
A phase 3b study of venetoclax and azacitidine or decitabine in an outpatient setting in patients with acute myeloid leukemia.
Hematol Oncol;
42(3): e3274, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38711253
2.
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.
Nat Med;
29(6): 1370-1378, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37188783
3.
A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer.
Lung Cancer;
163: 19-26, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34894455
4.
Zanubrutinib in patients with treatment-naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded-access study of 50 patients in the United States.
EJHaem;
4(1): 301-304, 2023 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36819162
5.
Phase 1/2 study of acalabrutinib and the PI3K delta inhibitor ACP-319 in relapsed/refractory B-cell Non-Hodgkin lymphoma.
Leuk Lymphoma;
63(7): 1728-1732, 2022 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35200084
6.
Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders.
Transplantation;
74(8): 1090-5, 2002 Oct 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12438952